Back to BlackRock, Inc. BlackRock, Inc.

APGEAPGE
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in APOGEE THERAPEUTICS INC

BlackRock, Inc. holds 5.5M shares of APGE (APOGEE THERAPEUTICS INC), worth $730.9M as of 2026-Q2. The position was increased (+34.8% shares). APGE represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$730.9M

Current Shares

5.5M

Total Value Change

+$556.1M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.5M
+34.8%
$730.9M0.0%$132.73
41
2026-Q1
Increased
4.1M
+8.0%
$343.9M0.0%$68.50
34
2025-Q4
Increased
3.8M
+40.9%
$285.6M0.0%$75.76
41
2025-Q3
Increased
2.7M
+4.8%
$106.7M0.0%$39.83
31
2025-Q2
Decreased
2.6M
-12.0%
$111.3M0.0%$43.38
0
2025-Q1
Decreased
2.9M
-4.4%
$108.7M0.0%$39.72
0
2024-Q4
Increased
3M
+2.3%
$137.9M0.0%$44.64
31
2024-Q3
First report
3M
-
$174.8M0.0%$57.99
0

Other major holders of APGE: FMR LLC, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used